ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30AG072947
National Institutes of Health
Grant: UL1TR001857
National Institutes of Health
Grant: U24AG021886
National Institutes of Health
Grant: P30AG024827
National Institutes of Health
Grant: DK56350
National Institutes of Health
Grant: R01AG074971
North Carolina Department of Health and Human Services
Grant: 00043095
National Institutes of Health
Grant: 3P30AG024827-06S2
Pittsburgh Older Americans Independence Center
National Institutes of Health
Grant: 5U24AG021886-18
National Cell Repository for Alzheimer's Disease (NCRAD)
National Institutes of Health
Grant: 3UL1TR001857-07S1
University of Pittsburgh Clinical and Translational Science Institute
National Institutes of Health
Grant: 3P30DK056350-19S1
Nutrition Obesity Research Center (NORC)
National Institutes of Health
Grant: 5P30AG072947-02
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG074971-03
Arterial Stiffness, Cognition, and Equol (ACE)
FWCI
3.94
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals